Preface (Introduction) [0.03%]
前言（介绍）
Ashwani K Singal
Ashwani K Singal
Not applicable. Thieme. All rights reserved.
Jordi Gratacós-Ginès,Edilmar Alvarado-Tapias,David Marti-Aguado et al.
Jordi Gratacós-Ginès et al.
Early forms of alcohol-associated liver disease (ALD) include different stages in the progression of compensated liver disease ranging from steatosis to steatohepatitis and fibrosis. ALD has been classically diagnosed at advanced stages mor...
Jie-Wen Zhang,Nan Zhang,Yi Lyu et al.
Jie-Wen Zhang et al.
The liver is a sexually dimorphic organ. Sex differences in prevalence, progression, prognosis and treatment do prevail in most liver diseases, and the mechanism of how liver diseases act differently among male versus female patients have n...
Current Concepts in Fluid Resuscitation and Vasopressor Use in Cirrhosis [0.03%]
当前肝硬化患者液体复苏与血管活性药物使用的概念
Madhumita Premkumar,Kamal Kajal,Pankaj Gupta et al.
Madhumita Premkumar et al.
Critically ill patients with cirrhosis and liver failure not uncommonly have hypotension due to multifactorial reasons, that include hyperdynamic state with increased cardiac index, low systemic vascular resistance due to portal hypertensio...
Qixiang Wu,Dashuai Yang,Chixiang Liu et al.
Qixiang Wu et al.
Alcohol-associated liver disease (ALD), primarily caused by chronic excessive alcohol consumption, is a leading cause of chronic liver disease worldwide. ALD includes alcohol-associated steatotic liver, alcohol-associated hepatitis (AH), fi...
Alexander M Washington,Enis Kostallari
Alexander M Washington
Progression of liver disease is dependent on intercellular signaling, including those mediated by extracellular vesicles (EVs). Within these EVs, microRNAs (miRNAs) are packaged to selectively silence gene expression in recipient cells for ...
Luan G Prado,Laura E Nagy
Luan G Prado
This review aims to summarize recent research using animal models, cell models, and human data regarding the role of complement in liver disease. Complement is part of the innate immune system and was initially characterized for its role in...
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology [0.03%]
肝脏病理生物学中的长链非编码RNA、RNA治疗和新兴技术
Abid A Anwar,Nidhi Jalan-Sakrikar,Robert C Huebert
Abid A Anwar
The field of ribonucleic acid (RNA) biology has revealed an array of noncoding RNA species, particularly long noncoding RNAs (lncRNAs), which play crucial roles in liver disease pathogenesis. This review explores the diverse functions of ln...
David Hudson,Francisco Javier Valentin Cortez,Ivonne Hurtado Díaz de León et al.
David Hudson et al.
There continues to be an ongoing need for fair and equitable organ allocation. The Model for End-Stage Liver Disease (MELD) score has evolved as a calculated framework to evaluate and allocate patients for liver transplantation objectively....
Zoe Mariño,Michael L Schilsky
Zoe Mariño
The Wilson disease (WD) research field is rapidly evolving, and new diagnostic and therapeutical approaches are expected to be change-gamers in the disease for the incoming years, after decades of slow changing options. Non-ceruloplasmin-bo...